Buclizine dihydrochloride (Buclina) is the hydrochloride salt form of buclizine, a piperazine histamine H1 receptor antagonist with primarily antiemetic and antivertigo activities. Buclizine dihydrochloride binds to and blocks the histamine H1 receptor, thereby preventing the symptoms that are caused by histamine activity. Buclizine dihydrochloride exerts its anti-emetic effect by binding to and blocking the muscarinic and histamine receptors in the vomiting center of the central nervous system (CNS). This may prevent activation of the chemoreceptor trigger zone (CTZ) and may reduce nausea and vomiting.
Molecular Weight:
505.95
Purity:
99.56%
CAS Number:
[129-74-8]
Formula:
C28H33ClN22HCl
Target:
Histamine Receptor|||5-HT Receptor|||AChR
T6426
* VAT and and shipping costs not included. Errors and price changes excepted
